ClinicalTrials.gg
RecruitingNCT07644624SLIDYUpdated Jun 17, 2026

Sling vs. Dynamic Shoulder Stabilizer After Soft Tissue Shoulder Instability Surgery (SLIDY)

An interventional study of Dynamic Immobilizer and Conventional fabric arm sling in Anterior Shoulder Instability, Shoulder Instability and Shoulder Dislocation, sponsored by Hospital Universitari de Bellvitge. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-17.

Sponsored by Hospital Universitari de Bellvitge · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized controlled trial seeks to address a significant clinical gap by evaluating the outcomes of two postoperative immobilization methods following arthroscopic soft tissue surgery for anterior shoulder instability: a standard static arm sling and a dynamic shoulder orthosis.

Read the detailed description

The present study is a pilot trial that aims to compare outcomes between patients immobilized using a standard arm sling and those managed with a dynamic shoulder orthosis (specifically, the medi® Shoulder action brace) following arthroscopic soft tissue stabilization for anterior shoulder instability. This trial will evaluate the impact of these two immobilization methods on early shoulder function, pain, recurrence, and patient satisfaction, while primarily assessing the feasibility of a future definitive trial. This is a prospective, single-center, pilot randomized controlled trial with parallel groups. Participants will be allocated in a 1:1 ratio to either the dynamic orthosis or the standard sling. The trial seeks to determine whether dynamic immobilization designed to facilitate controlled activity offers measurable advantages in early function, comfort, or recurrence risk compared to standard arm slings.

02

Conditions studied

  • Anterior Shoulder Instability
  • Shoulder Instability
  • Shoulder Dislocation

Browse trials for

Keywords

  • Arthroscopic Bankart Repair
  • Hill-Sachs Remplissage
  • Dynamic Shoulder Orthosis
  • Postoperative Immobilization
  • Shoulder Rehabilitation
03

In context

Shoulder Dislocation

105 studies on the registry are indexed under Shoulder Dislocation; 22 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 71 interventional studies indexed under Shoulder Dislocation.

Browse Shoulder Dislocation studies →

Lead sponsor

Hospital Universitari de Bellvitge is the lead sponsor of 120 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged ≥18 years undergoing arthroscopic soft-tissue stabilization for anterior shoulder instability (Bankart repair ± Hill-Sachs remplissage).
  • Ability and willingness to comply with the study protocol and scheduled follow-ups.
  • Provision of written .

Exclusion criteria

Exclusion Criteria:

  • Significant glenoid bone loss requiring bony augmentation procedures (e.g., bone block procedures, Latarjet).
  • Concomitant rotator cuff repair or fracture fixation.
  • to MRI (e.g., pacemaker, claustrophobia, incompatible implants).
  • Cognitive impairment, language barriers, or logistical inability to attend follow-up visits.
  • Previous ipsilateral shoulder surgery.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Dynamic Immobilizer

    Continuous wear of the dynamic shoulder orthosis for 3 weeks post-surgery, followed by a standardized physiotherapy protocol.

    Device: Dynamic Immobilizer

  • Active comparator
    Standard Arm Sling

    Continuous wear of a conventional fabric arm sling for 3 weeks post-surgery, followed by a standardized physiotherapy protocol.

    Device: Conventional fabric arm sling

Interventions

  • DeviceDynamic Immobilizer

    An adjustable strap system applied immediately post-surgery that permits movement of the shoulder joint while simultaneously limiting potentially harmful ranges of motion and translations. It is worn continuously for 3 weeks.

    Also known as: medi® Shoulder action brace

  • DeviceConventional fabric arm sling

    Static immobilization using a conventional fabric arm sling applied immediately post-surgery and worn continuously for 3 weeks.

06

What researchers measure

Primary outcomes

  1. Feasibility composite (Recruitment, Retention, and Adherence)

    Evaluation of the feasibility of conducting a definitive randomized controlled trial by measuring the recruitment rate (percentage of eligible enrolled), retention/follow-up completion rates, and protocol adherence (self-reported and therapist-verified). Safety and device-related adverse events will also be recorded.

    Time frame: Up to 12 months post-surgery.

Secondary outcomes

  1. Western Ontario Shoulder Instability Index (WOSI)

    Patient-reported functional outcome assessing quality of life related to shoulder instability.

    Time frame: Baseline, 3 weeks, 6 weeks, 3 months, 6 months, and 12 months.

  2. Rowe Score

    Clinical assessment of shoulder stability, mobility, and function.

    Time frame: Baseline, 3 weeks, 6 weeks, 3 months, 6 months, and 12 months.

  3. Constant-Murley Score

    Clinical assessment of general shoulder function, including pain, activities of daily living, range of motion, and strength.

    Time frame: Baseline, 3 weeks, 6 weeks, 3 months, 6 months, and 12 months.

  4. Subjective Shoulder Value (SSV)

    Patient-reported subjective function of the shoulder expressed as a percentage of a normal shoulder.

    Time frame: Baseline, 3 weeks, 6 weeks, 3 months, 6 months, and 12 months.

  5. Range of Motion (ROM)

    Active and passive flexion, abduction, and rotation measured via standardized goniometry by two blinded assessors.

    Time frame: Baseline, 3 weeks, 6 weeks, 3 months, 6 months, and 12 months.

  6. Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) Score

    Patient-reported outcome measure assessing physical function, symptoms, and related quality of life of the upper extremity.

    Time frame: Baseline, 3 weeks, 6 weeks, 3 months, 6 months, and 12 months.

  7. MRI Evaluation of Structural Healing

    Assessment of capsulolabral integrity and bone defect remodeling, scored as intact, partial, or re-tear by two blinded physicians.

    Time frame: Between 6 and 12 months post-surgery.

07

Study locations

1 of 1 sites recruiting
  • Bellvitge University Hospital
    L'Hospitalet de Llobregat, Catalonia 08907, Spain
    Recruiting
    • Abdul-ilah Hachem, MD · Contactabelhachem@gmail.com · +4609406030
    • Hady Ezzeddine, MD · Contacthadyezz@gmail.com
    • Abdul-ilah Hachem, MD · Principal investigator
    • Hady Ezzeddine, MD · Sub investigator
    • Xavi Rius, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — Data will be anonymized and stored in encrypted institutional servers in accordance with GDPR and HIPAA regulations. No data will be transferred to third parties outside the study team.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07644624
Responsible party
Abdul-ilah Hachem (Head of the Shoulder Surgery Unit, Department of Orthpaedic Surgery, Hospital Universitari de Bellvitge) — Principal investigator
First posted
Jun 12, 2026
Start date
Jun 15, 2026
Primary completion
Dec 15, 2027 (estimated)
Completion
Jun 15, 2028 (estimated)
Last update
Jun 17, 2026

Study contacts

Abdul-ilah Hachem, MD
Contact
abelhachem@gmail.com
+34609406030
Hady Ezzeddine, MD
Contact
hadyezz@gmail.com
Abdul-ilah Hachem, MD
principal investigator · Head of the Shoulder Unit, Department of Orthopaedics, Bellvitge Univeristy Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion